Comparison of Sevelamer and Calcium carbonat on magnesium serum level in hemodialyzed patients
Phase 3
- Conditions
- ESRD patients who hemodialyzed.End stage renal disease
- Registration Number
- IRCT20180831040912N1
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
ESRD patients who need hemodialysis 3 times week in 3 months
Serum Phosphorus level >5.4mg/dl
Exclusion Criteria
Those who did not complete the consent
Associated disease e.g acute heart & liver diseases
History of recent Diarrhea
History of Ileostomia or colostomia
History of major GI surgery
Patients who treated with Cyclosporin, Aminoglycosids, Amphotricin B, Furasemid and Thiazids
Patients who treated with PPI
Patients who had hypercalcemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Magnesium serum level. Timepoint: Before study and 3 months after treatment. Method of measurement: Photometric method.
- Secondary Outcome Measures
Name Time Method